With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).

Mervyn Tan, managing director, investment, at venture capital firm Vertex Holdings, will join the group to assume the roles, effective Jun 1. Singh, 61, will take on an advisory role from Jun 1, ST ...

Listen to Story Reshma Kewalramani named in TIME magazine's 100 Most Influential People 2025 First woman to lead a major US biotech firm in 2020 Vertex got FDA approval for CRISPR-based therapy under ...

Immersive training devices from Vertex Solutions are destined for the U.S. Air Force for the Fighter Bomber Fundamentals program. [Courtesy: Vertex Solutions] Vertex Solutions, a small business ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...